Priority pathogens and the antibiotic pipeline: an update.
作者信息
Beyer Peter, Paulin Sarah
机构信息
Department of Global Coordination and Partnership, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland.
出版信息
Bull World Health Organ. 2020 Mar 1;98(3):151. doi: 10.2471/BLT.20.251751.
Abstract
摘要
相似文献
1
Priority pathogens and the antibiotic pipeline: an update.重点病原体与抗生素研发进展：最新情况
Bull World Health Organ. 2020 Mar 1;98(3):151. doi: 10.2471/BLT.20.251751.
2
Antibiotic Pipeline Coordinators.抗生素管道协调员。
J Law Med Ethics. 2018 Jun;46(1_suppl):25-31. doi: 10.1177/1073110518782912.
3
Antibiotic development - economic, regulatory and societal challenges.抗生素研发——经济、监管及社会挑战
Nat Rev Microbiol. 2020 May;18(5):267-274. doi: 10.1038/s41579-019-0293-3. Epub 2019 Nov 19.
4
Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board.确保所需抗生素的可持续性：以飞镖靶为目标。
Ann Intern Med. 2019 Oct 15;171(8):580-582. doi: 10.7326/M19-1893. Epub 2019 Oct 8.
5
Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & discovery of new antibiotics in European countries.欧洲国家对世界卫生组织确定的用于新型抗生素研究与发现的重点病原体进行强制监测和疫情报告。
Clin Microbiol Infect. 2020 Jul;26(7):943.e1-943.e6. doi: 10.1016/j.cmi.2019.11.020. Epub 2019 Dec 5.
6
Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses.应对抗生素研发中的紧迫优先事项：来自世界卫生组织2023年抗菌药物临床研发管线分析的见解
Lancet Microbe. 2025 Mar;6(3):100992. doi: 10.1016/j.lanmic.2024.100992. Epub 2024 Oct 22.
7
World Health Organization, Department of essential drugs and medicines policy. WHO Workshop on containment of antimicrobial resistance in Europe, 26-27 February 2004 in Wernigerode, Germany.世界卫生组织，基本药物和药品政策司。2004年2月26日至27日在德国韦尔尼格罗德举办的欧洲抗菌药物耐药性遏制问题世卫组织研讨会。
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Feb;48(2):221-31. doi: 10.1007/s00103-004-0983-4.
8
The Therapeutic Pipeline for Pseudomonas aeruginosa Infections.铜绿假单胞菌感染的治疗途径
ACS Infect Dis. 2018 Jul 13;4(7):1041-1047. doi: 10.1021/acsinfecdis.8b00112. Epub 2018 May 17.
9
Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.多重耐药革兰氏阴性菌：近期获批抗生素及新型研发管线药物综述。
Int J Clin Pharm. 2020 Aug;42(4):1016-1025. doi: 10.1007/s11096-020-01089-y. Epub 2020 Jul 7.
10
Understanding current challenges of antibiotic resistance to find new solutions for 2050: scientific, medical and political issues.了解抗生素耐药性的当前挑战，为2050年寻找新的解决方案：科学、医学和政治问题。
Arch Microbiol. 2025 May 29;207(7):162. doi: 10.1007/s00203-025-04340-0.
引用本文的文献
1
Estimating the Value of Aztreonam-Avibactam in Treating Metallo-beta-Lactamase-Producing Enterobacterales Infections in Spain Using the STEDI AMR Value Framework.使用STEDI抗菌药物耐药性价值框架评估氨曲南-阿维巴坦在西班牙治疗产金属β-内酰胺酶肠杆菌科细菌感染中的价值。
Infect Dis Ther. 2025 Sep;14(9):2071-2092. doi: 10.1007/s40121-025-01202-6. Epub 2025 Jul 28.
2
Navigating the complexities of drug development for metallo-β-lactamase inhibitors.应对金属β-内酰胺酶抑制剂药物研发的复杂性。
RSC Med Chem. 2025 May 27. doi: 10.1039/d5md00035a.
3
Time-resolved X-ray solution scattering unveils the events leading to hemoglobin heme capture by staphylococcal IsdB.时间分辨X射线溶液散射揭示了葡萄球菌IsdB捕获血红蛋白血红素的过程。
Nat Commun. 2025 Feb 17;16(1):1361. doi: 10.1038/s41467-024-54949-w.
4
Synergizing Ecotoxicology and Microbiome Data Is Key for Developing Global Indicators of Environmental Antimicrobial Resistance.协同毒理学和微生物组数据对于开发环境抗微生物药物耐药性全球指标至关重要。
Microb Ecol. 2024 Nov 29;87(1):150. doi: 10.1007/s00248-024-02463-3.
5
Berberine-styrene--maleic acid nanomicelles: unlocking opportunities for the treatment and prevention of bacterial infections.小檗碱-苯乙烯-马来酸纳米胶束：为治疗和预防细菌感染带来机遇
RSC Adv. 2024 Oct 28;14(46):34066-34080. doi: 10.1039/d4ra04457f. eCollection 2024 Oct 23.
6
An Overview of the Recent Advances in Antimicrobial Resistance.抗菌药物耐药性的最新进展概述
Microorganisms. 2024 Sep 21;12(9):1920. doi: 10.3390/microorganisms12091920.
7
Prevalence and antimicrobial susceptibility patterns of bacteria colonizing the external ocular surfaces of patients undergoing ocular surgeries at Bugando Medical Center in Mwanza, Tanzania.在坦桑尼亚姆万扎的布甘达医疗中心接受眼部手术的患者的外眼表面定植细菌的流行情况和抗生素药敏模式。
BMC Res Notes. 2024 Jul 11;17(1):193. doi: 10.1186/s13104-024-06851-3.
8
Analysis of Antimicrobial Resistance in Bacterial Pathogens Recovered from Food and Human Sources: Insights from 639,087 Bacterial Whole-Genome Sequences in the NCBI Pathogen Detection Database.从食品和人类来源分离的细菌病原体的抗菌药物耐药性分析：来自NCBI病原体检测数据库中639,087个细菌全基因组序列的见解
Microorganisms. 2024 Mar 30;12(4):709. doi: 10.3390/microorganisms12040709.
9
Providing insight into the mechanism of action of cationic lipidated oligomers using metabolomics.利用代谢组学深入了解阳离子脂质体低聚物的作用机制。
mSystems. 2024 May 16;9(5):e0009324. doi: 10.1128/msystems.00093-24. Epub 2024 Apr 12.
10
Bacteriophage infection and killing of intracellular .噬菌体感染和杀伤细胞内的 。
mBio. 2024 Jan 16;15(1):e0292423. doi: 10.1128/mbio.02924-23. Epub 2023 Dec 7.
本文引用的文献
1
Non-traditional Antibacterial Therapeutic Options and Challenges.非传统抗菌治疗选择与挑战。
Cell Host Microbe. 2019 Jul 10;26(1):61-72. doi: 10.1016/j.chom.2019.06.004.
Zotero 插件